Essential Medicines in Developing Countries

Access to essential medicines is a critical component of achieving universal health coverage and improving health outcomes, particularly in developing countries. However, the availability and affordability of these life-saving treatments remain major challenges in these contexts. This chapter provides an overview of the issues surrounding essential medicines in developing countries, including factors influencing availability and affordability, challenges faced, and recommendations to improve the situation. Factors affecting availability and affordability include limited financial resources, weak healthcare infrastructure, limited local production capacity, intellectual property rights, and medicine selection processes. These factors contribute to challenges such as stockouts, high medicine prices, and limited access for vulnerable populations. To address these challenges, a range of recommendations are proposed. These include strengthening health systems, implementing universal health coverage initiatives, regulating medicine prices, promoting generic medicines, enhancing local production, utilizing intellectual property flexibilities, and improving supply chain management. Additionally, recommendations involve strengthening health education, research collaborations, and monitoring and evaluation systems. Implementing these recommendations requires collaboration among governments, international organizations, healthcare professionals, civil society, and the private sector. By improving the availability and affordability of essential medicines, developing countries can make significant progress in achieving better health outcomes and reducing health disparities. Continued commitment, investment, and policy reforms are crucial to sustain the improvements and ensure equitable access to essential medicines for all populations in developing countries.